BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19482004)

  • 1. Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4.
    Sharif O; Hu H; Klock H; Hampton EN; Nigoghossian E; Knuth MW; Matzen J; Anderson P; Trager R; Uno T; Glynne RJ; Azarian SM; Caldwell JS; Brinker A
    Anal Biochem; 2009 Sep; 392(2):162-8. PubMed ID: 19482004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of an allosteric model to describe the interactions among retinol binding protein 4, transthyretin, and small molecule retinol binding protein 4 ligands.
    Coward P; Conn M; Tang J; Xiong F; Menjares A; Reagan JD
    Anal Biochem; 2009 Jan; 384(2):312-20. PubMed ID: 18952041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus.
    Frey SK; Spranger J; Henze A; Pfeiffer AF; Schweigert FJ; Raila J
    Metabolism; 2009 Oct; 58(10):1386-92. PubMed ID: 19501859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ssDNA aptamer-based surface plasmon resonance biosensor for the detection of retinol binding protein 4 for the early diagnosis of type 2 diabetes.
    Lee SJ; Youn BS; Park JW; Niazi JH; Kim YS; Gu MB
    Anal Chem; 2008 Apr; 80(8):2867-73. PubMed ID: 18324839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenretinide derivatives act as disrupters of interactions of serum retinol binding protein (sRBP) with transthyretin and the sRBP receptor.
    Campos-Sandoval JA; Redondo C; Kinsella GK; Pal A; Jones G; Eyre GS; Hirst SC; Findlay JB
    J Med Chem; 2011 Jul; 54(13):4378-87. PubMed ID: 21591606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis.
    Dobri N; Qin Q; Kong J; Yamamoto K; Liu Z; Moiseyev G; Ma JX; Allikmets R; Sparrow JR; Petrukhin K
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):85-95. PubMed ID: 23211825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters.
    Henze A; Frey SK; Raila J; Scholze A; Spranger J; Weickert MO; Tepel M; Zidek W; Schweigert FJ
    Biochem Biophys Res Commun; 2010 Feb; 393(1):79-83. PubMed ID: 20097162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4.
    Wang Y; Connors R; Fan P; Wang X; Wang Z; Liu J; Kayser F; Medina JC; Johnstone S; Xu H; Thibault S; Walker N; Conn M; Zhang Y; Liu Q; Grillo MP; Motani A; Coward P; Wang Z
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2885-91. PubMed ID: 24835984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors.
    Zhou V; Han S; Brinker A; Klock H; Caldwell J; Gu XJ
    Anal Biochem; 2004 Aug; 331(2):349-57. PubMed ID: 15265741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of recombinant human retinol-binding protein in Pichia pastoris.
    Wysocka-Kapcinska M; Campos-Sandoval JA; Pal A; Findlay JB
    Protein Expr Purif; 2010 May; 71(1):28-32. PubMed ID: 20093188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of retinol-binding protein-transthyretin interaction and techniques to identify competing ligands.
    Mata NL; Phan K; Han Y
    Methods Mol Biol; 2010; 652():209-27. PubMed ID: 20552431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease.
    Goodman AB
    J Cell Physiol; 2006 Dec; 209(3):598-603. PubMed ID: 17001693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin.
    Zanotti G; Berni R
    Vitam Horm; 2004; 69():271-95. PubMed ID: 15196886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of surface plasmon resonance (SPR) and fluorescence resonance energy transfer (FRET) to monitor the interaction of the plant G-proteins Ms-Rac1 and Ms-Rac4 with GTP.
    Brecht M; Sewald K; Schiene K; Keen G; Fricke M; Sauer M; Niehaus K
    J Biotechnol; 2004 Aug; 112(1-2):151-64. PubMed ID: 15288950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.
    Cioffi CL; Muthuraman P; Raja A; Varadi A; Racz B; Petrukhin K
    J Med Chem; 2020 Oct; 63(19):11054-11084. PubMed ID: 32878437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of type 2 and type 1 diabetes on plasma RBP4 levels: the significance of transthyretin.
    Pullakhandam R; Palika R; Ghosh S; Reddy GB
    IUBMB Life; 2012 Dec; 64(12):975-82. PubMed ID: 23129325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid binding to retinol-binding protein and the interference with the interaction with transthyretin.
    Malpeli G; Folli C; Berni R
    Biochim Biophys Acta; 1996 May; 1294(1):48-54. PubMed ID: 8639713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and mutational analyses of protein-protein interactions between transthyretin and retinol-binding protein.
    Zanotti G; Folli C; Cendron L; Alfieri B; Nishida SK; Gliubich F; Pasquato N; Negro A; Berni R
    FEBS J; 2008 Dec; 275(23):5841-54. PubMed ID: 19021760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4.
    Du M; Martin A; Hays F; Johnson J; Farjo RA; Farjo KM
    Mol Vis; 2017; 23():185-197. PubMed ID: 28400700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus.
    Chen CC; Wu JY; Chang CT; Tsai FJ; Wang TY; Liu YM; Tsui HC; Chen RH; Chiou SC
    Metabolism; 2009 Dec; 58(12):1812-6. PubMed ID: 19709697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.